{"entity":{"type":"insider","cik":"0001315797","url":"/insider/0001315797","json_url":"/insider/0001315797.json","name":"Satter Muneer A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":105,"n_filings":53,"first":"2008-04-16","last":"2026-05-29","span_basis":"filed_date"},"name_variants":[{"name":"Satter Muneer A","source":"filing","n_filings":53,"first_seen":"2008-04-16","last_seen":"2026-05-29"}],"transactions":[{"id":5985807,"accession":"0001315797-26-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315797-26-000001","line_url":"/filing/0001315797-26-000001#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Annexon, Inc.","issuer_ticker":"ANNX","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":613497.0,"shares_display":"613,497","price_per_share":5.41,"price_display":"5.41","price_state":"stated","total_value":3319018.77,"total_display":"3,319,018.77","shares_owned_after":10342134.0,"shares_owned_after_display":"10,342,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-28","filed_date":"2026-05-29","scope":"insider"},{"id":4243496,"accession":"0001315797-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001315797-25-000007","line_url":"/filing/0001315797-25-000007#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Annexon, Inc.","issuer_ticker":"ANNX","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":422613.0,"shares_display":"422,613","price_per_share":4.28,"price_display":"4.28","price_state":"stated","total_value":1808783.64,"total_display":"1,808,783.64","shares_owned_after":9728637.0,"shares_owned_after_display":"9,728,637","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-21","scope":"insider"},{"id":4243492,"accession":"0001315797-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315797-25-000007","line_url":"/filing/0001315797-25-000007#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Annexon, Inc.","issuer_ticker":"ANNX","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":4.48,"price_display":"4.48","price_state":"stated","total_value":1792000.0,"total_display":"1,792,000.00","shares_owned_after":9306024.0,"shares_owned_after_display":"9,306,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-21","scope":"insider"},{"id":4316497,"accession":"0001315797-25-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001315797-25-000006","line_url":"/filing/0001315797-25-000006#line-3","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Annexon, Inc.","issuer_ticker":"ANNX","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":3.94,"price_display":"3.94","price_state":"stated","total_value":1970000.0,"total_display":"1,970,000.00","shares_owned_after":8906024.0,"shares_owned_after_display":"8,906,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-19","scope":"insider"},{"id":4316492,"accession":"0001315797-25-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001315797-25-000006","line_url":"/filing/0001315797-25-000006#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Annexon, Inc.","issuer_ticker":"ANNX","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":1590000.0,"total_display":"1,590,000.00","shares_owned_after":8406024.0,"shares_owned_after_display":"8,406,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-19","scope":"insider"},{"id":4316486,"accession":"0001315797-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315797-25-000006","line_url":"/filing/0001315797-25-000006#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Annexon, Inc.","issuer_ticker":"ANNX","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":2.99,"price_display":"2.99","price_state":"stated","total_value":1495000.0,"total_display":"1,495,000.00","shares_owned_after":7906024.0,"shares_owned_after_display":"7,906,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider"},{"id":8754305,"accession":"0001209191-23-059911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059911","line_url":"/filing/0001209191-23-059911#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Annexon, Inc.","issuer_ticker":"ANNX","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":2.88,"price_display":"2.88","price_state":"stated","total_value":1008000.0,"total_display":"1,008,000.00","shares_owned_after":7406024.0,"shares_owned_after_display":"7,406,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-28","scope":"insider"},{"id":8714753,"accession":"0001567619-23-002932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-002932","line_url":"/filing/0001567619-23-002932#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Annexon, Inc.","issuer_ticker":"ANNX","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2647058.0,"shares_display":"2,647,058","price_per_share":6.8,"price_display":"6.80","price_state":"stated","total_value":17999994.4,"total_display":"17,999,994.40","shares_owned_after":7056024.0,"shares_owned_after_display":"7,056,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-14","scope":"insider"},{"id":6188527,"accession":"0001567619-22-013890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-013890","line_url":"/filing/0001567619-22-013890#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Annexon, Inc.","issuer_ticker":"ANNX","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2453988.0,"shares_display":"2,453,988","price_per_share":3.84,"price_display":"3.84","price_state":"stated","total_value":9423313.92,"total_display":"9,423,313.92","shares_owned_after":4408966.0,"shares_owned_after_display":"4,408,966","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-07","filed_date":"2022-07-11","scope":"insider"},{"id":4122217,"accession":"0000899243-21-001163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-001163","line_url":"/filing/0000899243-21-001163#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000000.0,"shares_display":"9,000,000","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":9900000.0,"total_display":"9,900,000.00","shares_owned_after":16609449.0,"shares_owned_after_display":"16,609,449","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-08","scope":"insider"},{"id":3191841,"accession":"0001567619-20-013817","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-013817","line_url":"/filing/0001567619-20-013817#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Annexon, Inc.","issuer_ticker":"ANNX","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":3400000.0,"total_display":"3,400,000.00","shares_owned_after":1954978.0,"shares_owned_after_display":"1,954,978","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-28","scope":"insider"},{"id":2207799,"accession":"0000899243-20-015868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-015868","line_url":"/filing/0000899243-20-015868#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3700000.0,"shares_display":"3,700,000","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":4070000.0,"total_display":"4,070,000.00","shares_owned_after":7609449.0,"shares_owned_after_display":"7,609,449","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-09","scope":"insider"},{"id":8470797,"accession":"0000899243-19-000999","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-000999","line_url":"/filing/0000899243-19-000999#line-3","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23818.0,"shares_display":"23,818","price_per_share":2.4537,"price_display":"2.45","price_state":"stated","total_value":58442.2266,"total_display":"58,442.23","shares_owned_after":5621835.0,"shares_owned_after_display":"5,621,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-10","filed_date":"2019-01-10","scope":"insider"},{"id":8470793,"accession":"0000899243-19-000999","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-000999","line_url":"/filing/0000899243-19-000999#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.3938,"price_display":"2.39","price_state":"stated","total_value":47876.0,"total_display":"47,876.00","shares_owned_after":5598017.0,"shares_owned_after_display":"5,598,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-09","filed_date":"2019-01-10","scope":"insider"},{"id":8470789,"accession":"0000899243-19-000999","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-000999","line_url":"/filing/0000899243-19-000999#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.1986,"price_display":"2.20","price_state":"stated","total_value":43972.0,"total_display":"43,972.00","shares_owned_after":5578017.0,"shares_owned_after_display":"5,578,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-08","filed_date":"2019-01-10","scope":"insider"},{"id":8375425,"accession":"0000899243-19-000701","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-000701","line_url":"/filing/0000899243-19-000701#line-3","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.1779,"price_display":"2.18","price_state":"stated","total_value":43558.0,"total_display":"43,558.00","shares_owned_after":5558017.0,"shares_owned_after_display":"5,558,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-07","scope":"insider"},{"id":8375422,"accession":"0000899243-19-000701","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-000701","line_url":"/filing/0000899243-19-000701#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.1198,"price_display":"2.12","price_state":"stated","total_value":42396.0,"total_display":"42,396.00","shares_owned_after":5538017.0,"shares_owned_after_display":"5,538,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-04","filed_date":"2019-01-07","scope":"insider"},{"id":8375412,"accession":"0000899243-19-000701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-000701","line_url":"/filing/0000899243-19-000701#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.0754,"price_display":"2.08","price_state":"stated","total_value":41508.0,"total_display":"41,508.00","shares_owned_after":5518017.0,"shares_owned_after_display":"5,518,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-07","scope":"insider"},{"id":8690070,"accession":"0000899243-19-000196","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-000196","line_url":"/filing/0000899243-19-000196#line-3","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.9419,"price_display":"1.94","price_state":"stated","total_value":38838.0,"total_display":"38,838.00","shares_owned_after":5498017.0,"shares_owned_after_display":"5,498,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-02","scope":"insider"},{"id":8690064,"accession":"0000899243-19-000196","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-000196","line_url":"/filing/0000899243-19-000196#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.745,"price_display":"1.74","price_state":"stated","total_value":34900.0,"total_display":"34,900.00","shares_owned_after":5478017.0,"shares_owned_after_display":"5,478,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-31","filed_date":"2019-01-02","scope":"insider"},{"id":8690058,"accession":"0000899243-19-000196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-000196","line_url":"/filing/0000899243-19-000196#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.7186,"price_display":"1.72","price_state":"stated","total_value":34372.0,"total_display":"34,372.00","shares_owned_after":5458017.0,"shares_owned_after_display":"5,458,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-28","filed_date":"2019-01-02","scope":"insider"},{"id":6600623,"accession":"0000899243-18-031908","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-031908","line_url":"/filing/0000899243-18-031908#line-3","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.6705,"price_display":"1.67","price_state":"stated","total_value":33410.0,"total_display":"33,410.00","shares_owned_after":5438017.0,"shares_owned_after_display":"5,438,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-27","filed_date":"2018-12-27","scope":"insider"},{"id":6600620,"accession":"0000899243-18-031908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-031908","line_url":"/filing/0000899243-18-031908#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.6927,"price_display":"1.69","price_state":"stated","total_value":33854.0,"total_display":"33,854.00","shares_owned_after":5418017.0,"shares_owned_after_display":"5,418,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-27","scope":"insider"},{"id":6600617,"accession":"0000899243-18-031908","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-031908","line_url":"/filing/0000899243-18-031908#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.8435,"price_display":"1.84","price_state":"stated","total_value":36870.0,"total_display":"36,870.00","shares_owned_after":5398017.0,"shares_owned_after_display":"5,398,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-21","filed_date":"2018-12-27","scope":"insider"},{"id":6569466,"accession":"0000899243-18-031493","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-031493","line_url":"/filing/0000899243-18-031493#line-3","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.8492,"price_display":"1.85","price_state":"stated","total_value":36984.0,"total_display":"36,984.00","shares_owned_after":5378017.0,"shares_owned_after_display":"5,378,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-20","filed_date":"2018-12-20","scope":"insider"},{"id":6569464,"accession":"0000899243-18-031493","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-031493","line_url":"/filing/0000899243-18-031493#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.9192,"price_display":"1.92","price_state":"stated","total_value":38384.0,"total_display":"38,384.00","shares_owned_after":5358017.0,"shares_owned_after_display":"5,358,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-19","filed_date":"2018-12-20","scope":"insider"},{"id":6569460,"accession":"0000899243-18-031493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-031493","line_url":"/filing/0000899243-18-031493#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.9928,"price_display":"1.99","price_state":"stated","total_value":39856.0,"total_display":"39,856.00","shares_owned_after":5338017.0,"shares_owned_after_display":"5,338,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-18","filed_date":"2018-12-20","scope":"insider"},{"id":6217702,"accession":"0000899243-18-031136","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-031136","line_url":"/filing/0000899243-18-031136#line-3","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.0047,"price_display":"2.00","price_state":"stated","total_value":40094.0,"total_display":"40,094.00","shares_owned_after":5318017.0,"shares_owned_after_display":"5,318,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-14","filed_date":"2018-12-14","scope":"insider"},{"id":6217699,"accession":"0000899243-18-031136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-031136","line_url":"/filing/0000899243-18-031136#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.0154,"price_display":"2.02","price_state":"stated","total_value":40308.0,"total_display":"40,308.00","shares_owned_after":5298017.0,"shares_owned_after_display":"5,298,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-13","filed_date":"2018-12-14","scope":"insider"},{"id":6217693,"accession":"0000899243-18-031136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-031136","line_url":"/filing/0000899243-18-031136#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.0469,"price_display":"2.05","price_state":"stated","total_value":40938.0,"total_display":"40,938.00","shares_owned_after":5278017.0,"shares_owned_after_display":"5,278,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-14","scope":"insider"},{"id":6619448,"accession":"0000899243-18-030684","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-030684","line_url":"/filing/0000899243-18-030684#line-3","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.0923,"price_display":"2.09","price_state":"stated","total_value":41846.0,"total_display":"41,846.00","shares_owned_after":5258017.0,"shares_owned_after_display":"5,258,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-11","scope":"insider"},{"id":6619445,"accession":"0000899243-18-030684","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-030684","line_url":"/filing/0000899243-18-030684#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.1304,"price_display":"2.13","price_state":"stated","total_value":42608.0,"total_display":"42,608.00","shares_owned_after":5238017.0,"shares_owned_after_display":"5,238,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-11","scope":"insider"},{"id":6619442,"accession":"0000899243-18-030684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-030684","line_url":"/filing/0000899243-18-030684#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.1394,"price_display":"2.14","price_state":"stated","total_value":42788.0,"total_display":"42,788.00","shares_owned_after":5218017.0,"shares_owned_after_display":"5,218,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2018-12-11","scope":"insider"},{"id":6678875,"accession":"0000899243-18-030326","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-030326","line_url":"/filing/0000899243-18-030326#line-3","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.1792,"price_display":"2.18","price_state":"stated","total_value":43584.0,"total_display":"43,584.00","shares_owned_after":5198017.0,"shares_owned_after_display":"5,198,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-06","scope":"insider"},{"id":6678872,"accession":"0000899243-18-030326","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-030326","line_url":"/filing/0000899243-18-030326#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.0997,"price_display":"2.10","price_state":"stated","total_value":41994.0,"total_display":"41,994.00","shares_owned_after":5178017.0,"shares_owned_after_display":"5,178,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-04","filed_date":"2018-12-06","scope":"insider"},{"id":6678868,"accession":"0000899243-18-030326","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-030326","line_url":"/filing/0000899243-18-030326#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.9887,"price_display":"1.99","price_state":"stated","total_value":39774.0,"total_display":"39,774.00","shares_owned_after":5158017.0,"shares_owned_after_display":"5,158,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6138110,"accession":"0000899243-18-029916","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-029916","line_url":"/filing/0000899243-18-029916#line-3","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.9846,"price_display":"1.98","price_state":"stated","total_value":39692.0,"total_display":"39,692.00","shares_owned_after":5138017.0,"shares_owned_after_display":"5,138,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-11-30","scope":"insider"},{"id":6138107,"accession":"0000899243-18-029916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-029916","line_url":"/filing/0000899243-18-029916#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.0059,"price_display":"2.01","price_state":"stated","total_value":40118.0,"total_display":"40,118.00","shares_owned_after":5118017.0,"shares_owned_after_display":"5,118,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-11-30","scope":"insider"},{"id":6138104,"accession":"0000899243-18-029916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-029916","line_url":"/filing/0000899243-18-029916#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.9357,"price_display":"1.94","price_state":"stated","total_value":38714.0,"total_display":"38,714.00","shares_owned_after":5098017.0,"shares_owned_after_display":"5,098,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-28","filed_date":"2018-11-30","scope":"insider"},{"id":6376072,"accession":"0001280776-18-000089","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001280776-18-000089","line_url":"/filing/0001280776-18-000089#line-3","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7044777.0,"shares_display":"7,044,777","price_per_share":0.2916,"price_display":"0.29","price_state":"stated","total_value":2054256.9732,"total_display":"2,054,256.97","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-17","scope":"insider"},{"id":6376068,"accession":"0001280776-18-000089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001280776-18-000089","line_url":"/filing/0001280776-18-000089#line-2","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":447500.0,"shares_display":"447,500","price_per_share":0.3584,"price_display":"0.36","price_state":"stated","total_value":160384.0,"total_display":"160,384.00","shares_owned_after":7044777.0,"shares_owned_after_display":"7,044,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-14","filed_date":"2018-09-17","scope":"insider"},{"id":6376064,"accession":"0001280776-18-000089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001280776-18-000089","line_url":"/filing/0001280776-18-000089#line-1","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3890000.0,"shares_display":"3,890,000","price_per_share":0.4964,"price_display":"0.50","price_state":"stated","total_value":1930996.0,"total_display":"1,930,996.00","shares_owned_after":7492277.0,"shares_owned_after_display":"7,492,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-13","filed_date":"2018-09-17","scope":"insider"},{"id":6035289,"accession":"0000899243-18-018724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-018724","line_url":"/filing/0000899243-18-018724#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1818182.0,"shares_display":"1,818,182","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":7000000.7,"total_display":"7,000,000.70","shares_owned_after":5078017.0,"shares_owned_after_display":"5,078,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-28","filed_date":"2018-06-29","scope":"insider"},{"id":6407280,"accession":"0000899243-18-008446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-008446","line_url":"/filing/0000899243-18-008446#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","shares_owned_after":3259835.0,"shares_owned_after_display":"3,259,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-23","filed_date":"2018-03-23","scope":"insider"},{"id":6407277,"accession":"0000899243-18-008446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-008446","line_url":"/filing/0000899243-18-008446#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":4.8475,"price_display":"4.85","price_state":"stated","total_value":19390.0,"total_display":"19,390.00","shares_owned_after":3258835.0,"shares_owned_after_display":"3,258,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-21","filed_date":"2018-03-23","scope":"insider"},{"id":6177408,"accession":"0000899243-18-008259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-008259","line_url":"/filing/0000899243-18-008259#line-2","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5400.0,"shares_display":"5,400","price_per_share":4.9741,"price_display":"4.97","price_state":"stated","total_value":26860.14,"total_display":"26,860.14","shares_owned_after":3254835.0,"shares_owned_after_display":"3,254,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-20","filed_date":"2018-03-21","scope":"insider"},{"id":6177402,"accession":"0000899243-18-008259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-008259","line_url":"/filing/0000899243-18-008259#line-1","is_derivative":false,"issuer_cik":"0001315797","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001315797","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7600.0,"shares_display":"7,600","price_per_share":4.9638,"price_display":"4.96","price_state":"stated","total_value":37724.88,"total_display":"37,724.88","shares_owned_after":3249435.0,"shares_owned_after_display":"3,249,435","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-21","scope":"insider"},{"id":4551745,"accession":"0001280776-17-000104","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001280776-17-000104","line_url":"/filing/0001280776-17-000104#line-2","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":5.5714,"price_display":"5.57","price_state":"stated","total_value":278570.0,"total_display":"278,570.00","shares_owned_after":11382277.0,"shares_owned_after_display":"11,382,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-13","filed_date":"2017-12-14","scope":"insider"},{"id":4551738,"accession":"0001280776-17-000104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001280776-17-000104","line_url":"/filing/0001280776-17-000104#line-1","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":5.3953,"price_display":"5.40","price_state":"stated","total_value":269765.0,"total_display":"269,765.00","shares_owned_after":11332277.0,"shares_owned_after_display":"11,332,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2017-12-14","scope":"insider"},{"id":4174993,"accession":"0001280776-17-000102","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001280776-17-000102","line_url":"/filing/0001280776-17-000102#line-3","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001315797","owner_name":"Satter Muneer A","owner_url":"/insider/0001315797","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.9645,"price_display":"4.96","price_state":"stated","total_value":248225.0,"total_display":"248,225.00","shares_owned_after":11282277.0,"shares_owned_after_display":"11,282,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-11","filed_date":"2017-12-11","scope":"insider"}],"next_cursor":"2017-12-11|4174993","ledger_fault":false,"count":{"value":105,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":102,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":105},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001528115","name":"Annexon, Inc.","url":"/issuer/0001528115","role":"Director, Ten percent owner","n_filings":7,"first_seen":"2020-07-28","last_seen":"2026-05-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001420565","name":"AILERON THERAPEUTICS INC","url":"/issuer/0001420565","role":"Director, Officer, Ten percent owner, Other","n_filings":3,"first_seen":"2017-07-06","last_seen":"2021-01-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001422142","name":"Aerpio Pharmaceuticals, Inc.","url":"/issuer/0001422142","role":"Director, Ten percent owner","n_filings":13,"first_seen":"2017-03-17","last_seen":"2019-01-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001280776","name":"VITAL THERAPIES INC","url":"/issuer/0001280776","role":"Director, Ten percent owner","n_filings":13,"first_seen":"2014-04-23","last_seen":"2018-09-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001517022","name":"Akebia Therapeutics, Inc.","url":"/issuer/0001517022","role":"Director","n_filings":13,"first_seen":"2014-03-27","last_seen":"2017-07-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001404281","name":"Tokai Pharmaceuticals Inc","url":"/issuer/0001404281","role":"Ten percent owner","n_filings":1,"first_seen":"2014-09-24","last_seen":"2014-09-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001389072","name":"HeartWare International, Inc.","url":"/issuer/0001389072","role":"Ten percent owner","n_filings":3,"first_seen":"2008-04-16","last_seen":"2009-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001315797","retrieved_at":"2026-08-21T21:10:40+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}